It's a double blind clinical trials as mentioned numerous times so they wouldn't know. And they will be different testing environment and the more data RAP can gather, the better so it's actually a good announcement.
I thought it would at least increase it to 35c.....not to be as there is little buying pressure right not.
Ann: ResAppDx to be Formally Evaluated by Doctors Without Borders, page-77
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
